Combination of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients With Acute Decompensated Heart Failure With Preserved Left Ventricular Ejection Fraction: A Multicenter Study.
Shunsuke TamakiYoshiyuki NagaiRyu ShuttaDaisaku MasudaShizuya YamashitaMasahiro SeoTakahisa YamadaAkito NakagawaYoshio YasumuraYusuke NakagawaMasamichi YanoTakaharu HayashiShungo HikosoDaisaku NakataniYohei SotomiYasushi Sakatanull nullPublished in: Journal of the American Heart Association (2022)
Background Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are novel inflammation markers. Their combined usefulness for estimating the prognosis of patients with heart failure with preserved ejection fraction (HFpEF) admitted for acute decompensated heart failure remains elusive. Methods and Results We investigated 1026 patients registered in the Prospective Multicenter Observational Study of Patients with Heart Failure with Preserved Ejection Fraction. Both NLR and PLR values were measured at the time of admission. Comorbidity burden was defined as the number of occurrences of 8 common comorbidities of HFpEF. The primary end point was cardiac death. The patients were stratified into 3 groups based on the optimal cut-off values of NLR and PLR on the receiver operating characteristic curve analysis for predicting cardiac death (low NLR and PLR, either high NLR or PLR, and both high NLR and PLR). After a median follow-up of 429 days, 195 patients died, with 85 of these deaths attributed to cardiac causes. An increased comorbidity burden was significantly associated with a higher proportion of patients with high NLR (>4.5) or PLR (>193), or both. High NLR and PLR values were independently associated with cardiac death, and a combination of both values was the strongest predictor (hazard ratio, 2.66 [95% CI, 1.51%-4.70%], P =0.0008). A significant difference was found in the rate of cardiac death among the 3 groups stratified by NLR and PLR values. Conclusions The combination of NLR and PLR is useful for the prediction of postdischarge cardiac death in patients with acute HFpEF. Registration URL: ClinicalTrials.gov; Unique identifier: UMIN000021831.
Keyphrases
- ejection fraction
- left ventricular
- heart failure
- aortic stenosis
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- emergency department
- acute myocardial infarction
- hypertrophic cardiomyopathy
- prognostic factors
- clinical trial
- liver failure
- coronary artery disease
- mitral valve
- risk factors
- atrial fibrillation
- hepatitis b virus
- peripheral blood
- transcatheter aortic valve replacement
- single molecule
- drug induced
- catheter ablation
- acute heart failure